Back
Essilorluxottica Vs. Innate Pharma SA Industry Stock Comparison
Sell
45
ESLOY
Essilorluxottica
Last Price:
113.38
Seasonality Move:
3.33%
Sell
16
IPHA
Innate Pharma SA
Last Price:
2.16
Seasonality Move:
-4.78%
Sell
45
Essilorluxottica (ESLOY)
is a Sell
Is Essilorluxottica a Buy, Sell or Hold?
- The current Essilorluxottica [ESLOY] share price is $113.38. The Score for ESLOY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- ESLOY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $2.25. The Score for IPHA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ESLOY Stock Price Chart
What is Essilorluxottica's stock price today?
-
The Essilorluxottica share price today is $113.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ESLOY is experiencing slight selling pressure.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.25
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight buying pressure.
ESLOY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 40.87 | Sell |
| Chaikin Money Flow: | -67789 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.22 - 118.92) | Sell |
| Bollinger Bands (100): | (108.6 - 116.08) | Buy |
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.21 - 2.33) | Sell |
| Bollinger Bands (100): | (2.08 - 2.6) | Sell |
ESLOY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.14 | Sell |
| 20-day SMA: | 116.9 | Sell |
| 50-day SMA: | 114.12 | Sell |
| 200-day SMA: | 108.4 | Buy |
| 8-day EMA: | 115.06 | Sell |
| 20-day EMA: | 115.78 | Sell |
| 50-day EMA: | 114.66 | Sell |
| 200-day EMA: | 108.51 | Buy |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.25 | Sell |
| 20-day SMA: | 2.27 | Sell |
| 50-day SMA: | 2.23 | Buy |
| 200-day SMA: | 2.46 | Sell |
| 8-day EMA: | 2.25 | Sell |
| 20-day EMA: | 2.26 | Sell |
| 50-day EMA: | 2.26 | Sell |
| 200-day EMA: | 2.43 | Sell |
Essilorluxottica Earnings Growth & ESLOY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Essilorluxottica Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Innate Pharma SA Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||